MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

New Fentanyl TDS Approvals & Brand Names

Release issued 29th November 2008

Fentanyl TDS received approval from the United Kingdom, Taiwan and France Health Authorities, and it will be available in these markets in QI 2009, under the brand names FentamedTM, Fentanyl HPQ® and Fentanyl Biogaran®, respectively, in its four strengths: 25 mcg/h, 50 mcg/h, 75 mcg/h and 100 mcg/h.

Company details

If you want to find out more about the company visit Amarin Technologies S.A. profile.

Latest Amarin Technologies S.A. press releases

More Press Releases

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Need competitive intelligence information
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us